Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials

Background: The α-glucosidase inhibitors (AGIs) are commonly prescribed in Asian patients with type 2 diabetes mellitus (T2DM), but with a high incidence of gastrointestinal side effects. This study was aimed to compare the efficacy and safety of dipeptidyl peptidase-4 (DPP4) inhibitors and AGIs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaoliang, Zhao, Liang, Yu, Leilei, Yang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635585/
https://www.ncbi.nlm.nih.gov/pubmed/31354492
http://dx.doi.org/10.3389/fphar.2019.00777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635585/
https://www.ncbi.nlm.nih.gov/pubmed/31354492
http://dx.doi.org/10.3389/fphar.2019.00777

Ejemplares similares